Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Aptevo Therapeutics Inc. - Common Stock
(NQ:
APVO
)
2.400
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 12, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aptevo Therapeutics Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Is AMD Stock the Next Big AI Play?
August 02, 2023
Advanced Micro Devices (AMD) stock is in the news Wednesday as investors wonder if the tech company can succeed in the AI market!
Via
InvestorPlace
MTCH Stock Price Prediction: Can Match Group Rally 30% From Here?
August 02, 2023
Match Group (MTCH) stock is on the move Wednesday after getting a new price prediction and rating from BTIG analyst Jake Fuller.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 02, 2023
Via
Benzinga
Why Is Aptevo Therapeutics (APVO) Stock Down 33% Today?
August 02, 2023
Aptevo Therapeutics (APVO) stock is sliding lower on Wednesday after the biotechnology company announced a public share offering.
Via
InvestorPlace
Why Rover Group Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
August 02, 2023
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares surged 52.1% to $0.1049 in pre-market trading.
Via
Benzinga
Aptevo Therapeutics Reports 1Q23 Financial Results and Provides Business Update
May 11, 2023
Via
ACCESSWIRE
Overview Of Value Stocks In The Healthcare Sector
May 01, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
August 02, 2023
It's time for another breakdown of the biggest pre-market stock movers as we check out all of the latest news for Wednesday!
Via
InvestorPlace
Aptevo Therapeutics Inc. Announces Pricing of $5 Million Public Offering
August 01, 2023
Via
ACCESSWIRE
7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes
July 30, 2023
Although speculative trades are not for everyone, these millionaire-maker penny stocks could turn small bets into big returns.
Via
InvestorPlace
5 Value Stocks In The Healthcare Sector
July 24, 2023
Via
Benzinga
Aptevo Therapeutics Reports 2022 Financial Results and Provides Business Update
March 30, 2023
Via
ACCESSWIRE
Aptevo Therapeutics Raises $9.6 Million in Non-Dilutive Funding
March 30, 2023
Via
ACCESSWIRE
Overview Of Value Stocks In The Healthcare Sector
February 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
July 20, 2023
Via
Benzinga
Why Amarin Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 19, 2023
Gainers Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) rose 43% to $6.91.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 19, 2023
Via
Benzinga
Alligator Bioscience & Aptevo Therapeutics Announce Dosing of First Patient with ALG.APV-527 in Phase 1 Clinical Trial
February 13, 2023
Via
ACCESSWIRE
Aptevo Therapeutics Files Provisional Patent for Fifth Bispecific Antibody APVO711, Intended for the Treatment of Solid Tumors
January 09, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Intraday Session
July 18, 2023
Via
Benzinga
Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 18, 2023
Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring.
Via
Benzinga
Aptevo Therapeutics Stock Is Sinking Today - Here's Why
July 18, 2023
Aptevo Therapeutics Inc (NASDAQ: APVO) announced that its bispecific acute myelogenous leukemia (AML) drug candidate APVO436, in combination with venetoclax and azacitidine, achieved positive duration...
Via
Benzinga
Aptevo Announces Positive Duration of Remission Data from Phase 1b Expansion Trial Evaluating the Bispecific APVO436 for AML
July 18, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 04, 2023
Via
Benzinga
The Top 7 Growth Stocks in Biotech
March 03, 2023
The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
January 31, 2023
Investors can get ready for another busy day of trading with a breakdown of the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
December 14, 2022
On Wednesday, 115 stocks hit new 52-week lows.
Via
Benzinga
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
December 13, 2022
Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 13, 2022
Via
Benzinga
Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket
December 13, 2022
Gainers Netcapital Inc. (NASDAQ: NCPL) shares rose 91.3% to $2.65 in pre-market trading following Q2 results. Netcapital posted Q2 earnings of $0.04 per share on sales of $1.78 million.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.